Biomarker-driven therapy in endometrial cancer

Hannah Karpel, Brian Slomovitz, Robert L. Coleman, Bhavana Pothuri

Open source

DOI: 10.1136/ijgc-2022-003676
Published: 2023-03
Container: International Journal of Gynecological Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/ijgc-2022-003676,
  title = {Biomarker-driven therapy in endometrial cancer},
  author = {Hannah Karpel and Brian Slomovitz and Robert L. Coleman and Bhavana Pothuri},
  year = {2023},
  journal = {International Journal of Gynecological Cancer},
  doi = {10.1136/ijgc-2022-003676},
  url = {https://doi.org/10.1136/ijgc-2022-003676}
}

RIS

TY  - JOUR
TI  - Biomarker-driven therapy in endometrial cancer
AU  - Hannah Karpel
AU  - Brian Slomovitz
AU  - Robert L. Coleman
AU  - Bhavana Pothuri
PY  - 2023
JO  - International Journal of Gynecological Cancer
DO  - 10.1136/ijgc-2022-003676
UR  - https://doi.org/10.1136/ijgc-2022-003676
ER  -

APA

Karpel, H., Slomovitz, B., Coleman, R. L., & Pothuri, B. (2023). Biomarker-driven therapy in endometrial cancer. International Journal of Gynecological Cancer. https://doi.org/10.1136/ijgc-2022-003676

Source records

crossref · retrieved 2026-09-27T00:22:25.715Z